295 related articles for article (PubMed ID: 26013824)
1. Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis.
Szabó A; Ludwig M; Hegyi E; Szépeová R; Witt H; Sahin-Tóth M
J Biol Chem; 2015 Jul; 290(28):17282-92. PubMed ID: 26013824
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of mesotrypsin by chymotrypsin C prevents trypsin inhibitor degradation.
Toldi V; Szabó A; Sahin-Tóth M
J Biol Chem; 2020 Mar; 295(11):3447-3455. PubMed ID: 32014997
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic cellular role of the p.L104P human cationic trypsinogen variant in chronic pancreatitis.
Balázs A; Hegyi P; Sahin-Tóth M
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(7):G477-86. PubMed ID: 26822915
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk.
Beer S; Zhou J; Szabó A; Keiles S; Chandak GR; Witt H; Sahin-Tóth M
Gut; 2013 Nov; 62(11):1616-24. PubMed ID: 22942235
[TBL] [Abstract][Full Text] [Related]
5. Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants.
Geisz A; Hegyi P; Sahin-Tóth M
FEBS J; 2013 Jun; 280(12):2888-99. PubMed ID: 23601753
[TBL] [Abstract][Full Text] [Related]
6. Tighter Control by Chymotrypsin C (CTRC) Explains Lack of Association between Human Anionic Trypsinogen and Hereditary Pancreatitis.
Jancsó Z; Sahin-Tóth M
J Biol Chem; 2016 Jun; 291(25):12897-905. PubMed ID: 27129265
[TBL] [Abstract][Full Text] [Related]
7. Autoactivation of mouse trypsinogens is regulated by chymotrypsin C via cleavage of the autolysis loop.
Németh BC; Wartmann T; Halangk W; Sahin-Tóth M
J Biol Chem; 2013 Aug; 288(33):24049-62. PubMed ID: 23814066
[TBL] [Abstract][Full Text] [Related]
8. Mouse model suggests limited role for human mesotrypsin in pancreatitis.
Mosztbacher D; Sahin-Tóth M
Pancreatology; 2021 Mar; 21(2):342-352. PubMed ID: 33526384
[TBL] [Abstract][Full Text] [Related]
9. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
10. Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis.
Schnúr A; Beer S; Witt H; Hegyi P; Sahin-Tóth M
Gut; 2014 Feb; 63(2):337-43. PubMed ID: 23455445
[TBL] [Abstract][Full Text] [Related]
11. Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen.
Szabó A; Sahin-Tóth M
FEBS J; 2012 Dec; 279(23):4283-92. PubMed ID: 23035638
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive screening of chymotrypsin C (CTRC) gene in tropical calcific pancreatitis identifies novel variants.
Paliwal S; Bhaskar S; Mani KR; Reddy DN; Rao GV; Singh SP; Thomas V; Chandak GR
Gut; 2013 Nov; 62(11):1602-6. PubMed ID: 22580415
[TBL] [Abstract][Full Text] [Related]
13. Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.
Rosendahl J; Witt H; Szmola R; Bhatia E; Ozsvári B; Landt O; Schulz HU; Gress TM; Pfützer R; Löhr M; Kovacs P; Blüher M; Stumvoll M; Choudhuri G; Hegyi P; te Morsche RH; Drenth JP; Truninger K; Macek M; Puhl G; Witt U; Schmidt H; Büning C; Ockenga J; Kage A; Groneberg DA; Nickel R; Berg T; Wiedenmann B; Bödeker H; Keim V; Mössner J; Teich N; Sahin-Tóth M
Nat Genet; 2008 Jan; 40(1):78-82. PubMed ID: 18059268
[TBL] [Abstract][Full Text] [Related]
14. Risk of chronic pancreatitis in carriers of the c.180C>T (p.Gly60=) CTRC variant: case-control studies and meta-analysis.
Berke G; Beer S; Gede N; Takáts A; Szentesi A; Hegyi P; Rosendahl J; Sahin-Tóth M; Németh BC; Hegyi E
Pancreatology; 2023 Aug; 23(5):481-490. PubMed ID: 37321941
[TBL] [Abstract][Full Text] [Related]
15. Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation.
Szabó A; Radisky ES; Sahin-Tóth M
J Biol Chem; 2014 Feb; 289(8):4753-61. PubMed ID: 24403079
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of human chymotrypsin-like protease (CTRL) characterized by phage display-selected small-protein inhibitors.
Németh BZ; Nagy ZA; Kiss B; Gellén G; Schlosser G; Demcsák A; Geisz A; Hegyi E; Sahin-Tóth M; Pál G
Pancreatology; 2023 Sep; 23(6):742-749. PubMed ID: 37604733
[TBL] [Abstract][Full Text] [Related]
17. High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues.
Szabó A; Héja D; Szakács D; Zboray K; Kékesi KA; Radisky ES; Sahin-Tóth M; Pál G
J Biol Chem; 2011 Jun; 286(25):22535-45. PubMed ID: 21515688
[TBL] [Abstract][Full Text] [Related]
18. Genetic basis of chronic pancreatitis in Asia Pacific region.
Reddy DN; Prasad SS
J Gastroenterol Hepatol; 2011 Mar; 26 Suppl 2():2-5. PubMed ID: 21323990
[TBL] [Abstract][Full Text] [Related]
19. CFTR, SPINK1, PRSS1, and CTRC mutations are not associated with pancreatic cancer in German patients.
Schubert S; Traub F; Brakensiek K; von Kopylow K; Marohn B; Maelzer M; Gaedcke J; Kreipe H; Stuhrmann M
Pancreas; 2014 Oct; 43(7):1078-82. PubMed ID: 25003218
[TBL] [Abstract][Full Text] [Related]
20. Chymotrypsin C mutations in chronic pancreatitis.
Zhou J; Sahin-Tóth M
J Gastroenterol Hepatol; 2011 Aug; 26(8):1238-46. PubMed ID: 21631589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
